3P Learning Ltd (3PL)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.315 |
|---|---|
| 52-week range | 0.166 – 0.576 |
| Return, 1 month / 3 months | −8.0% / +13.0% |
| Return, 1 year / 3 years | −43.1% / −70.6% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 67.8% |
| Worst drawdown (1 year) | -67.2% |
| Average daily value traded | 0.01M AUD |
| Dividend yield | 11.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
3P Learning is an Australian education technology company that develops online learning programs for school students. Its products, including Mathletics and Reading Eggs, are used by schools and families to support mathematics and literacy learning through interactive digital lessons and activities. The company is based in Sydney and serves customers in Australia and overseas markets, working with teachers, students and parents who use its subscription-based learning platforms at school and at home.
The shares are listed on the Australian Securities Exchange in Australia under the code 3PL, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
3P Learning Ltd (3PL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.315 on 20 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 927 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 43.1% and over the last three months it rose 13.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.3% | ||
| From 52-week high | -45.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.0% | ||
| 6-month return | 27.3% | ||
| 12-month return, skipping the last month | -38.1% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -67.2% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M AUD | ||
| Zero-volume days | 36.7% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 11.2% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | −8.0% |
| 3 months | +13.0% |
| 6 months | +27.3% |
| 1 year | −43.1% |
| 3 years | −70.6% |
| 5 years | −73.7% |
Signals
| 50-day / 200-day average | 0.314 / 0.326 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.006 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | AUD 0.0352 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.